We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

By LabMedica International staff writers
Posted on 21 Sep 2023

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. More...

Now, researchers have leveraged cutting-edge genetic technology to develop Australia’s first-of-its-kind tool for detecting MPXV.

In a collaborative study, a team of scientists led by the Doherty Institute (Melbourne, Australia) has introduced MPXV-CRISPR, a diagnostic tool that can identify MPXV in clinical samples with remarkable precision and faster than any existing method, all thanks to CRISPR technology. This is Australia's first diagnostic method built on CRISPR to target the genetic markers unique to MPXV. Although CRISPR is best known for editing genomes, it's also proving valuable for developing highly sensitive diagnostic tools that can rapidly identify specific genetic markers of pathogens.

In order for MPXV-CRISPR to work, it needs to be configured to identify the virus. Using a collection of 523 MPXV genomes, the scientists engineered 'guides' that bind to the particular segment of the viral DNA they're looking for. Essentially, when a sample contains viral DNA, the CRISPR system latches on to the target and sends out a signal, indicating the virus is present. This approach can deliver accuracy and precision nearly equivalent to the well-established PCR methods, but it does so much more quickly.

One of the standout features of MPXV-CRISPR is the speed of diagnosis it offers. In line with the World Health Organization standards for diagnostic tests to be accurate, easily accessible, and cost-effective, the researchers are now in the process of transforming MPXV-CRISPR into a portable device. The aim is to make it available for quick, on-the-spot MPXV detection across the country. MPXV-CRISPR holds the promise to dramatically change how monkeypox is managed and significantly impact public health. The study was published in The Lancet Microbe.

“By improving access to quick and reliable diagnoses around Australia, including in places with limited resources and in remote areas, this decentralized approach to testing could enable faster treatment and improve patient outcomes, while fast-tracking our capacity to manage future outbreaks,” said Dr. Shivani Pasricha, a Senior Research Officer at WEHI, Junior Laboratory Head at the Doherty Institute.

Related Links:
Doherty Institute


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.